Trial intelligence / Profile preview

LiBBY: THC and CBD for Agitation in Dementia Patients in Hospice Care

NCT05644262Phase 2Completed

Sponsor
University of Southern California
Start
Jan 2024
Primary completion
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dronabinol, cannabidiol in agitation, sponsored by University of Southern California. Started Jan 2024; status: completed.

02

Drugs

dronabinolcannabidiol
03

Conditions

agitation

Beyond the preview

Go deeper on NCT05644262.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05644262.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call